Evidence map›Paper›PMID 41927541›Full record

ArticleNature communications2026

Exonic enhancers are a widespread class of dual-function regulatory elements.

Jean-Christophe Mouren, Magali Torres, Antoinette van Ouwerkerk, Iris Manosalva, Frederic Gallardo, Salvatore Spicuglia, Benoit Ballester

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jean-Christophe MourenAix Marseille Univ, INSERM, TAGC, Marseille, France.ORCID http://orcid.org/0000-0002-1543-6371
Magali Torres *Aix Marseille Univ, INSERM, TAGC, Marseille, France.ORCID http://orcid.org/0000-0002-7760-3809
Antoinette van Ouwerkerk *Aix Marseille Univ, INSERM, TAGC, Marseille, France.ORCID http://orcid.org/0000-0002-1583-1785
Iris ManosalvaAix Marseille Univ, INSERM, TAGC, Marseille, France.ORCID http://orcid.org/0000-0001-5756-2109
Frederic GallardoAix Marseille Univ, INSERM, TAGC, Marseille, France.ORCID http://orcid.org/0000-0002-8565-9730
Salvatore SpicugliaAix Marseille Univ, INSERM, TAGC, Marseille, France.ORCID http://orcid.org/0000-0002-8101-7108
Benoit BallesterAix Marseille Univ, INSERM, TAGC, Marseille, France. benoit.ballester@inserm.fr.ORCID http://orcid.org/0000-0002-0834-7135

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-23-CE12-0008-01EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) Eprom-101065610
6 · The paper itself

Abstract

Exonic enhancers (EEs) occupy an under-appreciated niche in gene regulation. By integrating transcription factor binding, chromatin accessibility, and high-throughput enhancer-reporter assays, we demonstrate that many protein-coding exons possess enhancer activity across species. These candidate EEs (cEEs) exhibit characteristic epigenomic signatures, form long-range interactions with gene promoters, and can be altered by both nonsynonymous and synonymous variants. CRISPR-mediated inactivation demonstrated the involvement of cEEs in the cis-regulation of host and distal gene expression. Through large-scale cancer genome analyses, we reveal that cEE mutations correlate with dysregulated target-gene expression and clinical outcomes, highlighting their potential relevance in disease. Evolutionary comparisons show that cEEs exhibit both strong sequence constraint and lineage-specific plasticity, suggesting that they serve ancient regulatory functions while also contributing to species divergence. Our findings expand the landscape of functional elements by establishing cEEs as a component of gene regulation, while revealing how coding regions can simultaneously fulfil both protein-coding and cis-regulatory roles.

Indexed as

Enhancer Elements, GeneticExonsAnimalsChromatinEvolution, MolecularGene Expression RegulationHumansMutationPromoter Regions, GeneticTranscription FactorsChromatinTranscription Factors

Identifiers

PMID41927541
PMCPMC13216554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.